<!DOCTYPE html>
<html lang="zh">
<head>
    <meta charset="UTF-8">
    <meta name="keywords" content=""/>
    <meta name="description" content="" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0" />
    <link rel="icon" href="./../../themes/halo_quickstarter/source/images/favicon.ico" type="image/x-icon" />
	<link rel="stylesheet" type="text/css" href="./../../themes/halo_quickstarter/source/plug/css.css">
	<link rel="stylesheet" href="./../../themes/halo_quickstarter/source/css/kico.css"/>
	<link rel="stylesheet" href="./../../themes/halo_quickstarter/source/css/hingle.css"/>
	<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css"/>
	<script type="text/javascript" src="./../../themes/halo_quickstarter/source/js/jquery.min.js"></script>
	<script type="text/javascript" src="./../../themes/halo_quickstarter/source/js/js.js"></script>
	<script type="text/javascript" src="./../../themes/halo_quickstarter/source/js/Top.js"></script>
	<script type="text/javascript" src="./../../themes/halo_quickstarter/source/js/time.js"></script>
	<script type="text/javascript" src="./../../themes/halo_quickstarter/source/js/count.js"></script>
	<!--script type="text/javascript" src="//api.html5media.info/1.2.2/html5media.min.js"></script-->
	<script type="text/javascript" id="wow"></script> 
	<script>
		$(function(){
			$(".li5").click(function() {
				$("html,body").animate({scrollTop:0}, 1000);
			});
		})
	</script>
    <meta name="generator" content="Halo 1.5.4"/>
    

    <meta name="referrer" content="never"><title>医疗设备三巨头“GPS”2025半年报出炉,拐点已现,强归在即! 展会快讯</title>
</head>
<!--##单页模块##-->
<body style="background-color: #ffffff">

<!--##pagetop##-->
<div class="header">
	<div class=" juzhong hidden-xs por DingBu" style="background-image:url(./../../upload/images/PcHead.jpg);background-color: #ced3d6;">
	</div>
</div>
<div id="nav-bar" class="clearfix">



	<div class="M-Nav" id="logo"> 
		<a href="#" class="Logo visible-xs"><img src="./../../upload/images/PhoneHead.jpg" alt="2023大湾区工博会- DMP大湾区工业博览会-深圳工博会"></a> 
	</div>
	<a href="javascript:;" class="M-Nav-btn"><div id="ToIndex"></div></a>
	<a href="./../.."  class="M-Nav-btn"><div id="ToIndex02"></div></a>
	<div id="nav">
			<ul>
			<li><a href="./../../index.html" target="_self">首页</a>
			</li>
			<li><a href="./../d3292d226c4235d140d1c713faa9e7f6####/index.html" target="_self">关于展会</a>
			 <div class='nav-down-list'>
				 <ul>
					<li><a href="./../../s/exhibition-summary/index.html" target="_self">展会介绍</a></li>
					<li><a href="./../../s/exhibition-hall/index.html" target="_self">展馆介绍</a></li>
					<li><a href="./../../s/中部工博会/index.html" target="_self">南昌工博会</a></li>
					<li><a href="./../../s/福州工博会/index.html" target="_self">福州工博会</a></li>
					<li><a href="./../../api/DMP香港工博会2023.pdf" target="_blank">香港工博会</a></li>
					<li><a href="/xt/cn/" target="_blank">展会展期</a></li>
				</ul>
			</div>
			</li>
			<li><a href="./../d3292d226c4235d140d1c713faa9e7f6####/index.html" target="_self">参展商</a>
			 <div class='nav-down-list'>
				 <ul>
					<li><a href="./../../categories/brand/index.html" target="_self">品牌榜</a></li>
					<li><a href="https://admin.dwqgbh.cn/nav/guestbook.htm" target="_self">展位申请</a></li>
				</ul>
			</div>
			</li>
			<li><a href="./../../categories/index.html" target="_self">新闻中心</a>
			 <div class='nav-down-list'>
				 <ul>
					<li><a href="./../../categories/message/index.html" target="_self">信息发布</a></li>
					<li><a href="./../../media/index.html" target="_self">媒体聚焦</a></li>
					<li><a href="./../index.html" target="_self">展会快讯</a></li>
					<li><a href="//tech.dwqgbh.cn/news/" target="_self">科技前沿资讯</a></li>
				</ul>
			</div>
			</li>
			<li><a href="./../../s/about/index.html" target="_self">关于我们</a>
			</li>
			<li><a href="./../d3292d226c4235d140d1c713faa9e7f6####/index.html" target="_self">联系我们</a>
			 <div class='nav-down-list'>
				 <ul>
					<li><a href="https://admin.dwqgbh.cn/nav/guestbook.htm" target="_self">展位申请</a></li>
					<li><a href="./../../s/individual/index.html" target="_self">观众报名</a></li>
					<li><a href="./../.." target="_self">✆137-6147-0961</a></li>
					<li><a href="mailto:1301150027@qq.com" target="_self">1301150027@qq.com</a></li>
				</ul>
			</div>
			</li>
			</ul>
	</div>


</div>
<div class="nav-bar-height visible-xs"></div>


<main>
    <div class="wrap min">
               
    <h2 style="text-align:center">医疗设备三巨头“GPS”2025半年报出炉,拐点已现,强归在即! </h2>
   <p style="text-align:center">梅斯智库  2025-08-06</p>
   <article class="post-content">
   
    <p><span leaf="" mpa-font-style="mdr8wslocyy">2025年过半，全球医疗设备巨头的业绩“成绩单”陆续揭晓。其中，GPS三家外企的财报被视为整个中国医疗设备市场的晴雨表。</span></p><p><span leaf=""><br/></span></p><p><span leaf="" mpa-font-style="mdr8wslo1a1f">过去两年，唱空的悲观情绪成为中国市场的主流——经济不好、政府缺钱、医院负债、反腐持续，医疗设备市场还能好起来吗？去年同期，整个市场基本都是两位数的负增长。但是半年度的财报却在显示：拐点可能已经出现。</span></p><p><span leaf=""><br/></span></p><ul><li><p><span leaf="" mpa-font-style="mdr8wslo1jqd">西门子医疗：全球医疗营收增长7%，中国区重拾增长，同比营收+2%。</span></p></li><li><p><span leaf="" mpa-font-style="mdr8wslo1jco">GE医疗：中国区营收与去年同期相比-2%，但上调全年指引。</span></p></li><li><p><span leaf="" mpa-font-style="mdr8wslo1u7">飞利浦医疗：中国区营收虽与去年同期相比-11%，但市场对飞利浦的“利润率上调 + 关税影响下调”反应积极，推动股价在纽约与阿姆斯特丹交易所双双上涨逾8%。</span></p></li></ul><p><span leaf="" mpa-font-style="mdr46n7mcv7"><br/></span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/0kAgTXnvfiaibdWa1N9MEYGiaL7RgcaicBAFSAMVbwFnXSWicuyJhDrWszF2bSqUegejFfuoWgZibCVAdPviadvdUY84A/640?wx_fmt=png&from=appmsg" class="rich_pages wxw-img js_insertlocalimg src" data-ratio="0.8675925925925926" data-s="300,640" data-type="png" data-w="1080" type="block" data-imgfileid="513698481" src="./../../static/load.gif"/></section><p><span leaf="" mpa-font-style="mdr8x9ku1zuj" data-mpa-action-id="mdr8x9lh1s5" data-pm-slice="0 0 []">中国市场始终是绕不开的关注焦点。大规模设备更新、集采的余波、招标的陆续推进、高端技术的角力，正共同重塑这个万亿赛道的格局。</span></p><p><span leaf="" mpa-font-style="mdr8x9ku1zuj" data-mpa-action-id="mdr8x9lh1s5" data-pm-slice="0 0 []">巨头们如何应对挑战？中国市场的“冰与火”又藏着哪些信号？</span></p><p><span mpa-font-style="mdr46n7n22rw"><span mpa-font-style="mdr48evf1qd6"><span leaf="" mpa-font-style="mdr48j3lhuc" data-mpa-action-id="mdr48j471qdx" data-pm-slice="0 0 []">01</span></span></span></p><p><span leaf="" mpa-font-style="mdr48evfj0i"><span textstyle="">业绩分化</span></span></p><p><span mpa-font-style="mdr46n7n1eio"><span mpa-font-style="mdr48evfe0i"><span leaf="">增长与承压并存，技术与区域成关键变量</span></span></span></p><p><span mpa-font-style="mdr46n7n1eio"><span mpa-font-style="mdr48evfe0i"><span leaf=""><br/></span></span></span></p><p><span leaf=""><span textstyle="">▐ </span></span><span leaf="" mpa-font-style="mdr9ou7dlyk" data-mpa-action-id="mdr9ou8n1xhq" data-pm-slice="0 0 []"><span textstyle="">西门子医疗：影像支撑增长</span></span></p><p><span leaf=""><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7n10yf"><span textstyle="">西门子医疗</span>最新发布的为2025财年Q3（截至2025年6月30日）业绩。根据计算，其2025上半年集团营收约115.7亿欧元（+7%）。</span></p><p><span leaf="" mpa-font-style="mdr494hz1oj3" data-mpa-action-id="mdr494ij1yok" data-pm-slice="0 0 []"><span textstyle="">*** 以下皆统计自2025年1月-6月财报数据</span></span></p><p><span leaf="" mpa-font-style="mdr494hz1oj3" data-mpa-action-id="mdr494ij1yok" data-pm-slice="0 0 []"><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7n5v5">受业绩改善及关税确定性提升利好，西门子医疗上调全年营收指引。</span></p><p><span leaf="" mpa-font-style="mdr46n7n1i5">CEO Bernd Montag强调，公司聚焦患者孪生、精准治疗、数字与AI三大技术，并通过200多个“价值合作伙伴关系”将收入转化为经常性收入。财报发布后，其股价在XETRA交易所当日上涨近2%。</span></p><p><span leaf="" mpa-font-style="mdr46n7na32"><span textstyle="">影像业务（占比56%）：</span>仍是西门子医疗第一大业务。营收65.21亿欧元，同比+10%。</span></p><ul><li><p><span leaf="" mpa-font-style="mdr46n7nchl">分子影像、CT收入增长显著，其中光子计数CT等高端产品贡献突出。</span></p></li><li><p><span leaf="" mpa-font-style="mdr46n7nleu">美洲市场增长强劲，亚太日本地区增长稳健，<span textstyle="">中国市场在去年同期低基数下实现显著增长</span>。</span></p><p><span leaf="" mpa-font-style="mdr46n7nleu"><br/></span></p></li></ul><p><span leaf="" mpa-font-style="mdr46n7nl8e"><span textstyle="">体外诊断业务：</span>营收21.81亿欧元，同比-1%。</span></p><ul><li><p><span leaf="" mpa-font-style="mdr46n7nw3x">EMEA和美洲市场收入增长，但受中国“集中带量采购（VBP）” 落地影响，2025年4月-6月中国市场收入低双位数下滑。</span></p><p><span leaf="" mpa-font-style="mdr46n7nw3x"><br/></span></p></li></ul><p><span leaf="" mpa-font-style="mdr46n7n1z5j"><span textstyle="">瓦里安：</span>营收20.19亿欧元，同比+10%。</span></p><ul><li><p><span leaf="" mpa-font-style="mdr46n7nhnw">中国和亚太日本市场增长显著，美洲市场增长强劲。</span></p><p><span leaf="" mpa-font-style="mdr46n7nhnw"><br/></span></p></li></ul><p><span leaf="" mpa-font-style="mdr46n7n1x2t"><span textstyle="">临床治疗业务：</span>营收10.37亿欧元，同比+3%。</span></p><ul><li><p><span leaf="" mpa-font-style="mdr46n7n21he">亚太日本市场增长显著，中国市场增长良好，美洲市场增长强劲。</span></p><p><span leaf="" mpa-font-style="mdr46n7n21he"><br/></span></p></li></ul><p><span leaf="" mpa-font-style="mdr46n7n18dq"><span textstyle="">从区域来看，</span></span></p><p><span leaf="" mpa-font-style="mdr46n7nte4"><span textstyle="">EMEA（包括欧盟、非洲、中东）：</span>营收36.41亿欧元，同比+2%。增长稳健，德国市场增长良好。</span></p><p><span leaf="" mpa-font-style="mdr46n7nuit"><span textstyle="">美洲区：</span>营收51.69亿欧元，同比+11%。表现最强劲，美国市场作为西门子医疗第一大市场，营收45.11亿欧元，同比+14%。</span></p><p><span leaf="" mpa-font-style="mdr46n7n1av"><span textstyle="">亚太区含日本（不含中国）：</span>营收15.25亿欧元，同比+7%。受益于高端设备需求。</span></p><p><span leaf="" mpa-font-style="mdr46n7n1u76"><span textstyle="">中国区（占比11%）：</span>营收12.35亿欧元，同比+2.4% 。增长主要依赖去年同期低基数；IVD受到集采执行影响。</span></p><p><span leaf="" mpa-font-style="mdr46n7n3e2"><br/></span></p><p data-pm-slice="2 2 []"><span leaf=""><span textstyle="">▐ </span></span><span leaf="" mpa-font-style="mdr9ou7dlyk" data-mpa-action-id="mdr9ou8n1xhq" data-pm-slice="0 0 []"><span textstyle="">GE医疗：中国市场回暖</span></span></p><p><span leaf="" mpa-font-style="mdr46n7n3e2"><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7nc5x"><span textstyle="">GE医疗</span>在2025年第二季度表现强劲，销售额高于华尔街预期。受健康的资本投资趋势、运营执行及关税税率变化影响，公司上调2025年指引，营收同比增长预期升至约3%。</span></p><p><span leaf="" mpa-font-style="mdr46n7n1pp6">2025上半年，集团营收97.84亿美元，同比增长3%。主要由服务收入增长驱动。</span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/0kAgTXnvfiaibdWa1N9MEYGiaL7RgcaicBAFQjn0LM23IJBgt67y5Cue6D984C2z6R4YTRtt16tlNGS8EIxkzDg4UQ/640?wx_fmt=png&from=appmsg" class="rich_pages wxw-img js_insertlocalimg src" data-ratio="0.25703125" data-s="300,640" data-type="png" data-w="1280" type="block" data-imgfileid="513698463" src="./../../static/load.gif"/></section><p><span leaf="" mpa-font-style="mdr46n7nkxi"><span textstyle="">影像（占比44%）：</span>营收43.44亿美元，同比+3%。</span></p><p><span leaf="" mpa-font-style="mdr4ekfwcsq" data-mpa-action-id="mdr4ekgnozy" data-pm-slice="0 0 []"><span textstyle="">*** 包括CT、MR、分子成像、X射线、女性健康、企业成像软件、服务和数字解决方案。</span></span></p><ul><li><p><span leaf="" mpa-font-style="mdr46n7n19yj">增长来自美国、欧洲市场的分子影像（MI/CT）和磁共振（MR）产品线，中国市场因政策刺激落地慢仍承压。</span></p></li></ul><p><span leaf=""><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7n1cfh"><span textstyle="">高级可视化解决方案AVS：</span>营收25.29亿美元，同比+2%。</span></p><p><span leaf="" mpa-font-style="mdr4eyjn1aza" data-mpa-action-id="mdr4eyk71jh9" data-pm-slice="0 0 []"><span textstyle="">*** 包括超声、图像引导治疗以及介入解决方案、外科创新。</span></span></p><ul><li><p><span leaf="" mpa-font-style="mdr46n7n11jm">美国市场需求强劲是主因，中国市场因医院采购延迟影响增长。</span></p></li></ul><p><span leaf=""><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7n47a"><span textstyle="">患者护理PCS：</span>营收15.31亿美元，同比+1%。</span></p><p><span leaf="" mpa-font-style="mdr4f8vj23l" data-mpa-action-id="mdr4f8w91qwm" data-pm-slice="0 0 []"><span textstyle="">*** 包括生命检测、麻醉和呼吸护理、母婴护理和心脏病诊断，以及耗材、服务和数字化解决方案。</span></span></p><ul><li><p><span leaf="" mpa-font-style="mdr46n7n729">监测解决方案（如生命体征监测）增长，生命支持设备（如呼吸机）同比基数较高导致增速放缓。</span></p></li></ul><p><span leaf=""><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7n21km"><span textstyle="">药物诊断PDx：</span>营收13.62亿美元，同比+10%。</span></p><p><span leaf="" mpa-font-style="mdr4fnmd45p" data-mpa-action-id="mdr4fnne1u8q" data-pm-slice="0 0 []"><span textstyle="">*** 包括对比剂和放射性药物、加强影像诊断。</span></span></p><ul><li><p><span leaf="" mpa-font-style="mdr46n7n1zdo">收购日本NMP贡献5300万美元，并受益于放射性药物的价格与销量增长。</span></p></li></ul><p><span leaf=""><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7n21ag"><span textstyle="">从区域来看，</span></span></p><p><span leaf=""><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7n1tu3"><span textstyle="">美国和加拿大地区：</span>营收45.77亿美元，同比+6%。所有细分领域全面增长。</span></p><p><span leaf="" mpa-font-style="mdr46n7n1df0"><span textstyle="">欧洲、中东和非洲地区：</span>营收24.42亿美元，同比+3%。影像业务增长，叠加有利外汇影响。</span></p><p><span leaf="" mpa-font-style="mdr46n7nfw4"><span textstyle="">中国地区（占比12%）：</span>营收11.56亿美元，同比-2%。PDx逆势增长，但影像和AVS需求放缓，地方政府医疗采购计划落地慢于预期，医院采购延迟。</span></p><p><span leaf="" mpa-font-style="mdr46n7nzyb"><span textstyle="">其他地区：</span>营收16.09亿美元，同比+1%。</span></p><p><span leaf="" mpa-font-style="mdr46n7nzyb"><br/></span></p><p data-pm-slice="2 2 []" data-mpa-action-id="mdr9ptdqtbv"><span leaf=""><span textstyle="">▐ </span></span><span mpa-font-style="mdr9ptdfid1"><span leaf=""><span textstyle="">飞利浦</span></span></span><span mpa-font-style="mdr9ou7dlyk" data-mpa-action-id="mdr9ou8n1xhq" data-pm-slice="0 0 []"><span mpa-font-style="mdr9ptdfguu"><span leaf=""><span textstyle="">：</span></span><span leaf=""><span textstyle="">整体盈利能力修复中</span></span></span></span></p><p><span leaf="" mpa-font-style="mdr46n7nzyb"><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7n1940"><span textstyle="">飞利浦</span>2025年上半年，集团总营收84.34亿欧元，同比下降2%。</span></p><p><span leaf=""><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7n1mdg">而得益于有效的缓解措施，飞利浦将2025年关税对业务的预估影响从之前的2.5-3亿欧元下调至1.5-2亿欧元（约1.731-2.308亿美元）。调整后的EBITA利润率从之前的预期上调50个基点，至11.3%-11.8%。财报发布后，飞利浦股价上涨超8%。</span></p><p><span leaf=""><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7ngqf">CEO Roy Jakobs表示，公司聚焦盈利增长，订单增长势头良好，并重申全年可比销售增长预期，同时上调利润率和自由现金流展望。</span></p><p><span leaf=""><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7n2221">从<span textstyle="">医疗业务（诊断与治疗+互联关护）</span>来看，</span><span leaf="" mpa-font-style="mdr46n7n2221" data-pm-slice="1 1 ["para",{"tagName":"p","attributes":{"style":"margin-bottom: 0px;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]">营收65.02亿欧元（</span><span leaf="" mpa-font-style="mdr46n7n2221" data-pm-slice="1 1 ["para",{"tagName":"p","attributes":{"style":"margin-bottom: 0px;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]">占77%</span><span leaf="" mpa-font-style="mdr46n7n2221" data-pm-slice="1 1 ["para",{"tagName":"p","attributes":{"style":"margin-bottom: 0px;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]">），同比下降3%。</span></p><p><span leaf=""><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7ncp3"><span textstyle="">诊断和治疗业务（占比48%）：</span>营收40.48亿欧元，同比-4%。</span></p><ul><li><p><span leaf="" mpa-font-style="mdr46n7n1iys">从细分领域来看，影像引导治疗业务的增长被精准诊断业务的下滑远超抵消。</span></p></li><li><p><span leaf="" mpa-font-style="mdr46n7nknl">从区域来看，成熟市场的可比销售额呈低个位数下降；增长型市场呈中个位数下降，主要受中国市场影响。</span></p></li></ul><p><span leaf=""><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7nt84"><span textstyle="">互联关护（占比29%）：</span>营收24.54亿欧元，同比-2%。</span></p><ul><li><p><span leaf="" mpa-font-style="mdr46n7n1ssm">从细分领域来看，监护业务出现低个位数下滑。</span></p></li><li><p><span leaf="" mpa-font-style="mdr46n7n20ik">从区域来看，尽管中国市场出现下滑，增长市场的可比销售额仍呈低个位数增长。</span></p></li></ul><p><span leaf=""><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7n1pik"><span textstyle="">从区域来看，</span></span></p><p><span leaf=""><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7n17nv"><span textstyle="">美国（占比41%）：</span>飞利浦第一大市场，营收34.76亿欧元，同比-0.1%。</span></p><p><span leaf="" mpa-font-style="mdr46n7n1srr"><span textstyle="">荷兰：</span>营收11.26亿欧元，同比+2.1%。</span></p><p><span leaf="" mpa-font-style="mdr46n7n1ylb"><span textstyle="">中国（占比7%）：</span>营收5.79亿欧元，同比-11%。</span></p><p><span leaf="" mpa-font-style="mdr46n7n23tk"><span textstyle="">日本：</span>营收4.69亿欧元，同比+0.9%。</span></p><p><span leaf="" mpa-font-style="mdr46n7n3ow"><span textstyle="">德国：</span>营收2.97亿欧元，同比-2%。</span></p><p><span leaf="" mpa-font-style="mdr46n7n1maq"><span textstyle="">其他国家：</span>营收24.87亿欧元，同比-4.3%。</span></p><p><span leaf="" mpa-font-style="mdr46n7n1maq"><br/></span></p><p><span mpa-font-style="mdr46n7n11l1"><span mpa-font-style="mdr4hlgq104w"><span leaf="" mpa-font-style="mdr4hogcl5g" data-mpa-action-id="mdr4hoh57lj" data-pm-slice="0 0 []">02</span></span></span></p><p><span leaf="" mpa-font-style="mdr4hlgqzcg"><span textstyle="">中国市场</span></span></p><p><span mpa-font-style="mdr46n7n19gn"><span mpa-font-style="mdr4hlgq1ggw"><span leaf="">短期挑战持续，长期潜力仍被巨头锁定</span></span></span></p><p><span mpa-font-style="mdr46n7n19gn"><span mpa-font-style="mdr4hlgq1ggw"><span leaf=""><br/></span></span></span></p><p><span leaf="" mpa-font-style="mdr46n7n16vm">在经历了2024年的逆风之后，领先医学影像企业在中国市场的业绩有所回暖；然而，中国医疗市场的挑战依旧严峻。</span></p><p><span leaf="" mpa-font-style="mdr46n7n8fn"><span textstyle="">西门子医疗</span>表示，中国的集采政策引发了行业性的价格体系重构，改变了商业模式和分销角色，这对公司诊断业务的全球增长和利润率均产生了影响，<span textstyle="">但总体影响相对较小</span>。</span></p><p><span leaf="" mpa-font-style="mdr46n7n1aj6">西门子医疗预计，中国集采导致的价格重构过程大约需要一年时间，预计到明年年中，全国市场价格水平将完成重构，届时<span textstyle="">增长将从新的较低起点逐步恢复</span>。</span></p><p><span leaf="" mpa-font-style="mdr46n7n13j1">针对中国限制欧盟医疗设备进口的消息，<span textstyle="">西门子医疗表示此政策对其业务并无实质性影响</span>。主要原因<span textstyle="">一是</span>公司大部分在华业务依托于本土化生产，<span textstyle="">二是</span>政策设定的门槛（约500万欧元）极高，相关情况极为罕见。</span></p><p><span leaf="" mpa-font-style="mdr46n7n22m9"><span textstyle="">尽管来自中国的逆风影响超出预期，但公司仍有信心实现年初设定的利润率扩张目标。</span></span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/0kAgTXnvfiaibdWa1N9MEYGiaL7RgcaicBAFwqGAF5zEovOlz2YokQVpxXpydbbkskQUMicvSkwvF5IFLhviaiaSXvNQA/640?wx_fmt=png&from=appmsg" class="rich_pages wxw-img js_insertlocalimg src" data-ratio="0.18611111111111112" data-s="300,640" data-type="png" data-w="1080" type="block" data-imgfileid="513698464" src="./../../static/load.gif"/></section><section><span leaf="" mpa-font-style="mdr4k6rohcu" data-mpa-action-id="mdr4k6stetv" data-pm-slice="0 0 []"><span textstyle="">GE医疗各区域营收</span></span></section><section><span leaf=""><br/></span></section><p><span leaf="" mpa-font-style="mdr46n7n1asg"><span textstyle="">GE医疗</span>表示，2025年第二季度中国市场积压订单改善情况良好超出预期；然而，公司对中国市场下半年的前景持谨慎态度。</span></p><p><span leaf="" mpa-font-style="mdr46n7n210f">尽管中国市场活动有所增加，但复苏进程较为缓慢，实际采购订单和购买行为的进展仍显滞后。省级招标周期延长，从投标到中标所需时间更长，预计下半年这一状况将持续存在。</span></p><p><span leaf="" mpa-font-style="mdr46n7n1i8y">2024年3月发布的中国医疗设备更新计划，从长期来看，这将有利于GE医疗在中国的业务发展；但短期内，由于各省制定计划和客户采购决策的进展慢于预期，将对订单和收入产生一定影响。</span></p><p><span leaf="" mpa-font-style="mdr46n7nn59">此外，在未来18至24个月内，<span textstyle="">GE医疗计划在全球范围内推出多款新产品，其中部分高端产品在中国市场将具有显著影响力</span>。这些高端产品主要将通过独立渠道销售。</span></p><p><span leaf="" mpa-font-style="mdr46n7n1um8"><span textstyle="">从长远来看，基于中国市场的规模和潜力，前景依然积极，中国市场仍是GE医疗重要的增长驱动力。</span></span></p><p><span leaf="" mpa-font-style="mdr46n7n1um8"><br/></span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/0kAgTXnvfiaibdWa1N9MEYGiaL7RgcaicBAFc3icBNYaUaJMHiaSibTK1BFqicV1hDEfUt5fjaQKbIFMH5NXyvKKleicicNA/640?wx_fmt=png&from=appmsg" class="rich_pages wxw-img js_insertlocalimg src" data-ratio="0.2601851851851852" data-s="300,640" data-type="png" data-w="1080" type="block" data-imgfileid="513698465" src="./../../static/load.gif"/></section><section><span leaf="" mpa-font-style="mdr4k6rohcu" data-mpa-action-id="mdr4k6stetv" data-pm-slice="1 1 ["para",{"tagName":"section","attributes":{"style":"text-align: center;margin-bottom: 0px;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]"><span textstyle="">飞利浦各区域营收</span></span></section><section><span leaf="" mpa-font-style="mdr4k6rohcu" data-mpa-action-id="mdr4k6stetv" data-pm-slice="1 1 ["para",{"tagName":"section","attributes":{"style":"text-align: center;margin-bottom: 0px;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]"><br/></span></section><p><span leaf="" mpa-font-style="mdr46n7ntow"><span textstyle="">飞利浦</span>表示，中国医疗设备市场的刺激措施和招标活动有所增加，但第二季度医疗设备业务增长仍较为缓慢。</span></p><p><span leaf="" mpa-font-style="mdr46n7n1p62"><span textstyle="">诊断与治疗业务预计在下半年订单和销量将有所改善</span>（环比提升），并逐步转为正增长。<span textstyle="">创新产品（如无氦MRI系统）在中国市场已获得一定程度的支持</span>。</span></p><p><span leaf="" mpa-font-style="mdr46n7n1zrz">近期，飞利浦全球管理层到访中国，与客户和政府进行深入沟通，确认市场的长期潜力。</span></p><p><span leaf="" mpa-font-style="mdr46n7n1nct">此外，美中双边贸易关税的预期低于此前的假设。而针对中国市场成本通胀问题，飞利浦通过优化供应链（如调整供应商网络）积极应对。</span></p><p><span leaf="" mpa-font-style="mdr46n7npfb">尽管飞利浦对中国市场2025年全年持谨慎态度，但长期来看，<span textstyle="">公司依然看好中国市场的前景。预计中国业务将逐步恢复至此前的中个位数增长水平</span>，但这一进程较为缓慢。</span></p><p><span leaf="" mpa-font-style="mdr4mfmu7rz" data-mpa-action-id="mdr4mfn41m7b" data-pm-slice="0 0 []"><span textstyle="">03</span></span></p><p><span mpa-font-style="mdr46n7nj4e"><span mpa-font-style="mdr4mcejs7b"><span leaf="">中国医疗设备招投标</span></span></span></p><p><span mpa-font-style="mdr46n7n4f9"><span mpa-font-style="mdr4mcekbjm"><span leaf="">影像赛道领跑，头部技术竞逐</span></span></span></p><p><span mpa-font-style="mdr46n7n4f9"><span mpa-font-style="mdr4mcekbjm"><span leaf=""><br/></span></span></span></p><p><span leaf="" mpa-font-style="mdr46n7n1nty">据医装数据统计分析来看，<span textstyle="">医学影像仍然是中国医疗设备市场中增速最快的细分领域</span>，2025年1月至5月的整体同比增速超过100%。</span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/0kAgTXnvfiaibdWa1N9MEYGiaL7RgcaicBAF9icwtzYyXiaXS7UKqbKgIChhqDb67PSZIO399ZnGVZOVKUibZTHojGlOg/640?wx_fmt=png&from=appmsg" class="rich_pages wxw-img js_insertlocalimg src" data-ratio="0.5611111111111111" data-s="300,640" data-type="png" data-w="1080" type="block" data-imgfileid="513698466" src="./../../static/load.gif"/></section><p><span leaf="" mpa-font-style="mdr46n7n1gvn">从中国市场2025年上半年的医院中标情况来看，外资和民营企业呈现出多元竞争的态势。具体而言，与2024年相比（按中标金额计算），在DR领域，万东医疗跃居首位；在CT领域，西门子医疗升至榜首。</span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/0kAgTXnvfiaibdWa1N9MEYGiaL7RgcaicBAFQuPplWcB39nkjTcQLXzm8FY3XMAeIADAV8licN7ibRbXUAjrEPA0O4HQ/640?wx_fmt=png&from=appmsg" class="rich_pages wxw-img js_insertlocalimg src" data-ratio="0.4546296296296296" data-s="300,640" data-type="png" data-w="1080" type="block" data-imgfileid="513698467" src="./../../static/load.gif"/></section><p><span leaf="" mpa-font-style="mdr4nrlx2c1" data-mpa-action-id="mdr4nrmx13ba" data-pm-slice="0 0 []"><span textstyle="">*** 数据来源：医招采、众成数科，（按中标金额）</span></span></p><p><span leaf="" mpa-font-style="mdr4nrlx2c1" data-mpa-action-id="mdr4nrmx13ba" data-pm-slice="0 0 []"><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7n14gi">2025年上半年，在医学影像和超声领域（按中标金额计算），市占率前三名合计占比分别为：DR约46%、CT约66%、MRI约72%、DSA约85%、超声约73%。<span textstyle="">除DR和超声市场外，其余各领域的市场集中度均有所下降。</span></span></p><p><span leaf="" mpa-font-style="mdr46n7n1ox8">而医学影像领域头部企业展开的新一轮技术较量，超高端产品似乎成为市场决胜的关键赛道。从2025年上半年超高端医疗设备项目的中标情况来看，GE医疗、西门子医疗、飞利浦位列前三。</span></p><section nodeleaf=""><img class="rich_pages wxw-img js_insertlocalimg src" data-imgfileid="513698468" data-ratio="0.5444444444444444" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/0kAgTXnvfiaibdWa1N9MEYGiaL7RgcaicBAFUmK4fGia5alqqmWY8rp7icn5BH79DP1j6pF6RqOrZNcs3QHoNFGQx5Iw/640?wx_fmt=png&from=appmsg" data-type="png" data-w="1080" type="block" src="./../../static/load.gif"/></section><p><span leaf="" mpa-font-style="mdr4pe8u1rtj" data-mpa-action-id="mdr4pe9n23la" data-pm-slice="0 0 []"><span textstyle="">*** 数据来自中国政府采购网，人工不完全统计，仅供参考</span></span></p><p><span leaf="" mpa-font-style="mdr4pe8u1rtj" data-mpa-action-id="mdr4pe9n23la" data-pm-slice="0 0 []"><br/></span></p><p><span leaf="" mpa-font-style="mdr46n7n1xwv">已历时一年多的医疗设备更新项目，也是各企业关注的焦点。据众成数科统计，2025年上半年，在中国医疗设备更新项目中，已披露预算金额的项目审批数量共计212个，总金额高达153.4亿元。在这些项目中，拟采购频率最高的五类产品依次为超声、CT、MR、DR和DSA。</span></p><p><span leaf="" mpa-font-style="mdr46n7n24oo">从上半年已完成招标的项目来看，不乏数亿元级别的大项目，且多数由国产厂商中标。</span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/0kAgTXnvfiaibdWa1N9MEYGiaL7RgcaicBAFDA3Sls4Nkkjr2gF6VjuoKFqibMeNURdtBZnfFYlia1mB2dHibVcZQpLrw/640?wx_fmt=png&from=appmsg" class="rich_pages wxw-img js_insertlocalimg src" data-ratio="1.151851851851852" data-s="300,640" data-type="png" data-w="1080" type="block" data-imgfileid="513698469" src="./../../static/load.gif"/></section><p><span leaf="" mpa-font-style="mdr8w0hc1egz" data-mpa-action-id="mdr8w0i3pk8" data-pm-slice="0 0 []">短期挑战与长期潜力交织的中国医疗设备市场，正倒逼全球巨头以高端技术深耕破局、以本土化应变。影像等核心赛道的竞逐已进入深水区，而随着集采重构、招标落地与创新迭代的持续推进，万亿市场的新秩序，正在冰与火的碰撞中加速成型。</span></p><p><span leaf="" mpa-font-style="mdr8w0hc1egz" data-mpa-action-id="mdr8w0i3pk8" data-pm-slice="0 0 []"><br/></span></p><section class="mp_profile_iframe_wrp" nodeleaf=""><mp-common-profile class="js_uneditable custom_select_card mp_profile_iframe" data-pluginname="mpprofile" data-nickname="梅斯智库" data-alias="MedSci_thinktank" data-from="0" data-headimg="http://mmbiz.qpic.cn/mmbiz_png/pvjGOHxaibgVdibxmjAWrlYhufJpq1TVN6Evvpw4fLwhOWk0FiaAK1fppRjib0RrmnyRfV4JtjsK5GTOF835mNCtAw/0?wx_fmt=png" data-signature="独立医学智库，提供医学学术与产业深度洞察" data-id="Mzg3MDY1NjgwMw==" data-is_biz_ban="0" data-service_type="1" data-verify_status="2"/></section><p><mp-style-type data-value="3"/></p> 
        
         </article>
   <script type="text/javascript" src="./../../nav/jquery.lazyload.src.js"></script>
   <script type="text/javascript" charset="utf-8">
  $(function() {
      $("img.src").lazyload({ placeholder : "./../../static/load.gif",effect: "fadeIn"});
  });
</script>

    </div>
</main>



    <div class="footer" style="background-color: #ced3d6">

            <div class="w80 juzhong">
                <img class="wybf" src="./../../upload/images/footzhuban.png" style="width: 100%;z-index:99">
              <img class="sjbf" src="./../../upload/images/footzhuban1.png" style="width: 100%;z-index:99">
                    <p class="wybf" style="color: black" class="footer-copytxt">COPYRIGHT <a href="https://beian.miit.gov.cn/"  target="_blank">沪ICP备16029818号-3</a> GBAIE Co., Ltd. All right reserved  <br/>备案号：<a href="http://beian.miit.gov.cn/" target="_blank"><span style="color:black">沪ICP备16029818号-3</span></a>
                    </p>
                    <p class="sjbf" style="color: black;padding-top: 30px;text-align: center;clear: both;width: 90%;padding-left: 30px;" class="footer-copytxt"><a href="https://beian.miit.gov.cn/"  target="_blank">沪ICP备16029818号-3</a> COPYRIGHT <a href="https://beian.miit.gov.cn/"  target="_blank">沪ICP备16029818号-3</a> GBAIE Co., Ltd. All right reserved <br>
                    </p>
            </div>
	</div> 
    
    
<!-- 实现PC端右侧界面侧边栏 -->
    <ul id="scrollSearchDiv" class="rightline wybf" >
    <!--二维码图片div-->
        <li class="li2" ></li>
        <li class="li1" ></li>
        <div class="flex wybf"></div>
    <style type="text/css">
    	.li4::before {
          content:'\e612';
          font-size: 27px;
    	}
    </style>

        <div class="flex1 wybf">

        </div>
        <!--<li class="li4"></li>
        <div class="flex2 wybf"></div>-->
        <li class="li5"></li>
    </ul>
</body>
</html>